Inactive Instrument
Company CEREP Euronext Paris
Stocks
FR0004042232
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 08-25 | Lotus Bakeries, the most expensive speculoos on the (stock) market in Europe |  |
| 04-29 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Business description: CEREP
Export accounts for 88.2% of net sales.
Sales by Activity: CEREP
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Pre-Private Clinics | 41.63M | 47.65M | 44.07M | 40.49M | 41.1M |
Geographical breakdown of sales: CEREP
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Export | 37.82M | 46.53M | 41.5M | 37.09M | 36.13M |
France | 3.8M | 1.09M | 2.57M | 3.37M | 4.84M |
Unallocated | - | - | 2.37K | 30.54K | 124K |
Executive Committee: CEREP
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 2024-04-10 |
Composition of the Board of Directors: CEREP
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 2023-08-10 |
Damien Vielliard
BRD | Director/Board Member | - | 2024-05-22 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
Company details: CEREP
Eurofins-Cerep SA
2 rue du Professeur Gargouïl
86600, Celle l'Evescault
+33 5 49 89 30 00
http://www.eurofins.fr/cerep/
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | +4.16% | +49.37% | +94.17% | 74.31B | |
| +2.76% | -1.60% | +22.80% | +78.53% | 56.95B | |
| +0.24% | -1.34% | +3.41% | +34.31% | 48.3B | |
| -3.76% | -2.25% | +329.09% | +698.20% | 44.51B | |
| -2.30% | -3.35% | +26.81% | +30.88% | 43.8B | |
| +0.31% | -0.68% | +5.30% | +108.64% | 41.12B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.07B | |
| -3.80% | -0.54% | +32.74% | +24.16% | 28.97B | |
| -1.96% | -2.88% | -8.97% | -13.92% | 24.53B | |
| Average | -0.49% | -0.75% | +52.19% | +123.07% | 43.73B | |
| Weighted average by Cap. | +0.16% | -0.92% | +56.37% | +132.18% |
- Stock Market
- Stocks
- ALECR Stock
- Stock
- Company CEREP
Select your edition
All financial news and data tailored to specific country editions
